List of Excipients in API TELITHROMYCIN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing TELITHROMYCIN
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Physicians Total Care Inc | KETEK | telithromycin | 54868-5171 | CELLULOSE, MICROCRYSTALLINE | |
| Physicians Total Care Inc | KETEK | telithromycin | 54868-5171 | CROSCARMELLOSE SODIUM | |
| Physicians Total Care Inc | KETEK | telithromycin | 54868-5171 | FERRIC OXIDE RED | |
| Physicians Total Care Inc | KETEK | telithromycin | 54868-5171 | FERRIC OXIDE YELLOW | |
| Physicians Total Care Inc | KETEK | telithromycin | 54868-5171 | HYPROMELLOSES | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for TELITHROMYCIN
Excipient focus: CELLULOSE, MICROCRYSTALLINE
TELITHROMYCIN drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
TELITHROMYCIN drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
TELITHROMYCIN drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
TELITHROMYCIN drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
TELITHROMYCIN drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
TELITHROMYCIN drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
TELITHROMYCIN drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
TELITHROMYCIN drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
TELITHROMYCIN drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
TELITHROMYCIN drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | telithromycin | 54868-5171 |
| >Company | >Ingredient | >NDC |
TELITHROMYCIN drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch